cyclohexanol has been researched along with cholecystokinin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acsady, L; Freund, TF; Hajos, N; Katona, I; Ledent, C; Mackie, K; Rancz, EA | 1 |
| Edwards, GL; Freeman, KG; Johnston, JR | 1 |
2 other study(ies) available for cyclohexanol and cholecystokinin
| Article | Year |
|---|---|
Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission.
Topics: Amygdala; Analgesics; Animals; Benzoxazines; Cannabinoid Receptor Modulators; Cannabinoids; Cholecystokinin; Cyclohexanols; gamma-Aminobutyric Acid; Interneurons; Male; Membrane Potentials; Mice; Mice, Knockout; Morpholines; Naphthalenes; Nerve Net; Neural Inhibition; Organ Specificity; Patch-Clamp Techniques; Presynaptic Terminals; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Receptors, GABA-A; Synaptic Transmission | 2001 |
Activity in nodose ganglia neurons after treatment with CP 55,940 and cholecystokinin.
Topics: Animals; Cannabinoid Receptor Agonists; Cells, Cultured; Cholecystokinin; Cyclohexanols; Male; Neurons; Nodose Ganglion; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley | 2018 |